These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34570456)

  • 1. Toward the Next Generation of High-Grade Glioma Clinical Trials in the Era of Precision Medicine.
    Rahman R
    Cancer J; 2021 Sep-Oct 01; 27(5):410-415. PubMed ID: 34570456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
    Janiaud P; Serghiou S; Ioannidis JPA
    Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel chemotherapeutics and other therapies for treating high-grade glioma.
    Kang JH; Adamson C
    Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical trial designs for testing biomarker-based personalized therapies.
    Lai TL; Lavori PW; Shih MC; Sikic BI
    Clin Trials; 2012 Apr; 9(2):141-54. PubMed ID: 22397801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-grade glioma therapy: adding flexibility in trial design to improve patient outcomes.
    Ye X; Schreck KC; Ozer BH; Grossman SA
    Expert Rev Anticancer Ther; 2022 Mar; 22(3):275-287. PubMed ID: 35130447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New clinical trial designs for establishing drug efficacy and safety in a precision medicine era.
    Heerspink HJL; List J; Perkovic V
    Diabetes Obes Metab; 2018 Oct; 20 Suppl 3(Suppl Suppl 3):14-18. PubMed ID: 30294954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New clinical trial design in precision medicine: discovery, development and direction.
    Duan XP; Qin BD; Jiao XD; Liu K; Wang Z; Zang YS
    Signal Transduct Target Ther; 2024 Mar; 9(1):57. PubMed ID: 38438349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches.
    Rood BR; MacDonald TJ
    J Neurooncol; 2005 Dec; 75(3):267-72. PubMed ID: 16195804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical considerations of neuro-oncology trial design in the era of precision medicine.
    Gupta S; Smith TR; Broekman ML
    J Neurooncol; 2017 Aug; 134(1):1-7. PubMed ID: 28555425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Biomarker Assessment in Gliomas: Impacts of Molecular Testing on Clinical Practice and Trial Design.
    Lim-Fat MJ; Nayak L; Meredith DM
    Surg Pathol Clin; 2020 Jun; 13(2):209-215. PubMed ID: 32389262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of prognostic and predictive factors into glioma clinical trials.
    Johnson DR; Galanis E
    Curr Oncol Rep; 2013 Feb; 15(1):56-63. PubMed ID: 23125011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Glioma in the 21st Century: An Exciting Decade of Postsurgical Treatment Advances in the Molecular Era.
    Uhm JH; Porter AB
    Mayo Clin Proc; 2017 Jun; 92(6):995-1004. PubMed ID: 28578786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric Gliomas: BRAF and Histone H3 as Biomarkers, Therapy and Perspective of Liquid Biopsies.
    Tan JY; Wijesinghe IVS; Alfarizal Kamarudin MN; Parhar I
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33557011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 2 trial design in neuro-oncology revisited: a report from the RANO group.
    Galanis E; Wu W; Cloughesy T; Lamborn K; Mann B; Wen PY; Reardon DA; Wick W; Macdonald D; Armstrong TS; Weller M; Vogelbaum M; Colman H; Sargent DJ; van den Bent MJ; Gilbert M; Chang S
    Lancet Oncol; 2012 May; 13(5):e196-204. PubMed ID: 22554547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecularly targeted therapies for malignant gliomas: advances and challenges.
    Penas-Prado M; Gilbert MR
    Expert Rev Anticancer Ther; 2007 May; 7(5):641-61. PubMed ID: 17492929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment.
    Israel E; Denlinger LC; Bacharier LB; LaVange LM; Moore WC; Peters MC; Georas SN; Wright RJ; Mauger DT; Noel P; Akuthota P; Bach J; Bleecker ER; Cardet JC; Carr TF; Castro M; Cinelli A; Comhair SAA; Covar RA; Alexander LC; DiMango EA; Erzurum SC; Fahy JV; Fajt ML; Gaston BM; Hoffman EA; Holguin F; Jackson DJ; Jain S; Jarjour NN; Ji Y; Kenyon NJ; Kosorok MR; Kraft M; Krishnan JA; Kumar R; Liu AH; Liu MC; Ly NP; Marquis MA; Martinez FD; Moy JN; O'Neal WK; Ortega VE; Peden DB; Phipatanakul W; Ross K; Smith LJ; Szefler SJ; Teague WG; Tulchinsky AF; Vijayanand P; Wechsler ME; Wenzel SE; White SR; Zeki AA; Ivanova A
    J Allergy Clin Immunol; 2021 May; 147(5):1594-1601. PubMed ID: 33667479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatment strategies for malignant gliomas.
    Sathornsumetee S; Rich JN
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemispherical Pediatric High-Grade Glioma: Molecular Basis and Therapeutic Opportunities.
    Haase S; Nuñez FM; Gauss JC; Thompson S; Brumley E; Lowenstein P; Castro MG
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New molecular targets in malignant gliomas.
    de Groot JF; Gilbert MR
    Curr Opin Neurol; 2007 Dec; 20(6):712-8. PubMed ID: 17992095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.